![](/img/cover-not-exists.png)
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies
Body, J J, Diel, I J, Lichinitzer, M, Lazarev, A, Pecherstorfer, M, Bell, R, Tripathy, D, Bergstrom, BVolume:
90
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/sj.bjc.6601663
Date:
March, 2004
File:
PDF, 109 KB
english, 2004